Ysios Capital Partners, SGEIC, S.A.U.

Ysios Capital Partners, SGEIC, S.A.U. is a private equity and venture capital firm specializing in seed/startups, early, mid stage, pre IPO financing, emerging growth, growth capital and bridge investments. It invests in early stage companies looking for first round funding through later-stage or pharmaceutical spin-off companies. The firm seeks to invest in human healthcare innovations, life science, digital health, healthcare, and biotechnology sectors with a focus on pharmaceuticals, biomedicine, diagnostics, medical devices, ehealth, and medical technology sectors and disruptive products, platforms or technologies in the pharmaceutical and medtech and diagnostics segments. It seeks to invest in development of therapeutic and diagnostic products. It seeks to invest in product development projects and rarely invests in services. It targets companies that focus on product development in the biotechnology, emerging pharmaceuticals, healthcare and medical technology sectors. The firm prefers to invest in North America and Europe with a focus on Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Liechtenstein, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom. It invests between $1.22 million and $22.69 million and can also provide additional capital for follow on investments. The firm seeks to take a board seat in its portfolio companies. It typically holds it investments for a period of four years to six years and seeks to exit via public offering or mergers and acquisitions. Ysios Capital Partners, SGEIC, S.A.U. was founded in 2008 and is based in Donostia-San Sebastián, Spain with additional offices across Europe and North America.